Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Occupationally related disorders are commonly due to injury or to working conditions that involve physical strain, such as hand-arm vibration or performing the same movement repetitively. These disorders are not the focus of the present chapter, which is concerned instead with the consequences of exposure to neurotoxins in the workplace. Many of the chemical agents present in the workplace environment may produce behavioral, cognitive, motor, sensory, or autonomic disturbances resulting from disorders of the central or peripheral nervous system (CNS or PNS). Exposure to such neurotoxic substances may affect workers using them or involved in their manufacture as well as those exposed in industrial, agricultural, horticultural, or military settings. The occurrence of such occupationally related neurotoxic disorders has been known for centuries, but their prevalence is unknown.
In order to demonstrate that a particular chemical is neurotoxic or that a certain syndrome is due to neurotoxin exposure, it must be shown that the suspected neurotoxin causes neurologic dysfunction of a consistent nature in exposed humans. The disorder occurring in one subject must be consistent in character with that occurring in others exposed to the same chemical agent. The neurologic manifestations must be related temporally to exposure to the presumed toxin, and their subsequent course should accord with the biologic properties of that toxin. In other words, the clinical disorder must be biologically plausible. The nature of the toxin and the intensity of exposure will determine how soon after exposure any symptoms develop. The neurologic dysfunction may vary in severity between individuals but—depending on their level of exposure—all exposed workers should have some signs of neurotoxicity. Involvement of a single worker suggests that the disorder is not due to a toxin, that toxin exposure did not occur at work, or that exposure resulted from some individual work habit, such as failure to use a protective mask. Diagnosis of an occupationally related neurotoxic disorder may be difficult when symptoms are common and nonspecific and may occur for a variety of reasons. Moreover, once a neurotoxic disorder is suspected, identical symptoms may develop in suggestible subjects with little or no exposure to the presumed toxin.
Ideally, to establish the toxic basis of a neurologic disorder, it should be possible to identify reproducible pathologic or pathophysiologic changes in the nervous system in humans or experimentally in animals, and these should account for the clinical features of the disorder. In practice, it is often not feasible to reproduce a suspected neurotoxic syndrome in animals. Variation in species susceptibility may be responsible, and certain impairments (e.g., cognitive or affective disturbances) are anyway difficult to reproduce in animals. Furthermore, human exposure is often to combinations of several chemicals, which individually may be harmless but in combination lead to neurologic dysfunction. This is because the effects of the different chemicals may be additive or one may potentiate the neurotoxic effects of another, as is illustrated by the effect of adding the nontoxic methyl ethyl ketone to a lowered concentration of the known neurotoxin n -hexane, a practice that led in the past to an outbreak of toxic neuropathy.
The temporal profile of the clinical disorder may be informative. Depending on the toxic agent, there is often little or no latent period between the time of exposure and onset of symptoms, but certain toxic neuropathies (arsenic, thallium, organophosphates) occur after a delay on the order of 2 to 3 weeks. Although cessation of exposure may lead to clinical stabilization or improvement, deterioration may continue for some days to weeks after termination of exposure to certain neurotoxins, a phenomenon termed “coasting.”
Improvement of symptoms during periods away from work, such as at weekends or during vacations, may raise the possibility of a work-related exposure to a neurotoxin, but other factors may be responsible, such as anxiety or disputes with co-workers. These various points are summarized in Table 35-1 .
History of exposure to a potential neurotoxin |
Pattern of neurologic dysfunction accords with previously reported cases |
Exposed co-workers also affected |
A temporal relation exists between toxin exposure and onset of symptoms, and between cessation of exposure and arrest of progression (sometimes after coasting) |
If the pathologic and pathophysiologic bases of the disorder have been identified, they should be reproducible and account for the clinical disturbance; an animal model of the disorder may exist |
Other causes of the disorder have been excluded |
Attention must be directed at distinguishing between a neurotoxic and pseudoneurotoxic disorder. The latter may relate to a psychogenic illness or to the coincidental onset or worsening of an unrelated or pre-existing disorder. Pseudoneurotoxic disorders may be accompanied or followed by the multiple chemical sensitivity syndrome, and by affective symptoms, lassitude, malaise, and social withdrawal. The underlying pathophysiology is unclear and there is no specific treatment, but any mood disturbance requires treatment.
There are usually no specific clinical manifestations of a neurotoxic disorder. The symptoms and signs are frequently indistinguishable from those of other neurologic disorders. General examination may, however, reveal additional features suggestive of a toxic cause, such as the presence of hyperkeratosis and desquamation of the skin of the palms and soles and of Mees lines in the nails of patients with arsenic exposure.
An acute encephalopathy is a common but nonspecific manifestation that may consist solely of headache and malaise that settle shortly after exposure is discontinued. With more severe involvement, symptoms may come to include confusion, irritability, poor concentration, impaired judgment, drowsiness, vertigo, tinnitus, sensory complaints, ataxia, weakness or fatigue, and nausea and vomiting. Neurologic examination is usually normal. Neuropsychologic examination may be abnormal but, because recovery is rapid and complete (usually within 24 hours), is rarely performed. With continued exposure, level of consciousness becomes depressed, sometimes leading to coma; seizures may also occur. Recovery is then likely to be more protracted and may be incomplete. The cause of this acute syndrome usually is easy to determine because of the history of exposure, because many workers are affected, and because a variety of other manifestations are common, such as conjunctival, mucosal, and cutaneous irritation, and respiratory difficulties.
The occurrence of a chronic encephalopathy relating to long-term low-level neurotoxin exposure is widely reported but of uncertain validity. Its symptoms include headache, “dizziness,” poor concentration, memory impairment, irritability, affective disorders, various sleep disturbances, loss of libido, numbness and paresthesias, and “weakness.” Such symptoms are nonspecific in nature, usually mild in degree, but may lead to surprising disability. Examination is typically normal, but ataxia and nystagmus are sometimes found; the results of laboratory and electrophysiologic studies are generally unhelpful or of questionable significance or relevance. Neurobehavioral studies may be abnormal, but often the findings are inconsistent, difficult to interpret in the absence of premorbid baseline studies, and of uncertain relevance. At present, then, whether such an entity truly exists—and its pathophysiologic basis—remains unclear.
Peripheral neuropathy is a better understood consequence of toxin exposure in the workplace. It may occur as a delayed effect of single high-dose exposure or after short-term repeated exposure to certain organophosphates, arsenic, or thallium. Chronic exposure to these and other neurotoxins, such as acrylamide and many organic solvents, also leads to neuropathy, causing that portion of the axon farthest from the cell body to degenerate, a phenomenon described as a distal axonal neuropathy or axonopathy , or a dying-back neuropathy. Its clinical features are similar to those of neuropathies of other etiologies. Symptoms and signs begin distally in the legs and then progress proximally depending on the severity of exposure. Sensory axons pass both peripherally to the limbs and centrally into the spinal cord; both degenerate toward the cell body. Some of the central sensory fibers ascend in the posterior columns to the cuneate and gracile nuclei in the medulla and, because of their length, are often among the first to degenerate. As regeneration does not occur in the CNS, recovery after axonal degeneration will be incomplete despite effective regeneration of the peripheral nerves.
The presence of abnormalities on general examination may help to suggest a toxic cause of the neuropathy. For example, sweating and bullous dermatitis of the hands is found in acrylamide toxicity, and scalp alopecia occurs with thallium poisoning.
In subjects who are chronically exposed to other neurotoxins in the workplace but who have no clinical deficit, minor electrodiagnostic abnormalities are sometimes found. Although these will not necessarily progress to clinical neuropathy, such subjects need careful monitoring to limit exposure and minimize any risk of progression.
Screening workers for signs of toxicity may help to identify individuals with incipient or subclinical neurologic dysfunction or exposure to low levels of a neurotoxin, and thereby limit further exposure. Screening of fellow workers may also be diagnostically helpful when a subject with a suspected, occupationally related, neurotoxic disorder is encountered, because similarly exposed workers are likely to have at least some symptoms and signs of intoxication, although to a varying degree that probably relates to differences in age, gender, ethnicity, genetic background, health status, and other factors. In general, however, screening techniques are insensitive and poorly tolerated by patients. They are also expensive and time-consuming.
An occupational history is an important part of the medical record, especially when patients with obscure neurologic disorders are encountered. Job titles may need clarification for the nature of an occupation to be appreciated. If exposure to toxins is suspected, a detailed list of chemicals used in the workplace—and at previous places of employment, if symptoms are longstanding—should be obtained. Details of the work environment are also important, such as whether it is well ventilated, the nature of any protective measures (such as a requirement to wear special clothing and gloves, and the use of other devices including masks and goggles), and the provisions made for washing after exposure and for storage of food. The most common routes of occupational exposure are inhalation and through the skin.
It may be necessary to question co-workers to determine whether they have similar symptoms to those of a subject with a suspected neurotoxic disorder, and even to examine those working in a similar environment. When asymptomatic but exposed co-workers are screened, questioning may be focused, based on the clinical features in recognized cases; self-administered, standardized symptom questionnaires may be especially helpful.
Neurotoxin exposure may also relate to environmental factors (such as a subject’s residence or its location close to, for example, an industrial plant) and to social and personal factors (such as hobbies, other recreational activities, or dietary peculiarities) rather than to the workplace. The history must therefore exclude these possibilities.
Routine neurologic examination is of limited utility for screening purposes, its principal role being to exclude other conditions that might underlie the patient’s symptoms. Generalized rather than focal neurologic abnormalities are the expected finding in many neurotoxic disorders. In some instances, however, focal findings—such as parkinsonism from manganese exposure—may be conspicuous. Techniques have been developed for quantifying aspects of the neurologic—especially the sensory—examination for screening purposes and for following changes over time. These include quantitative tests of muscle strength, coordination, body sway, balance, vibration and discriminative tactile sensibility, cold and warm thermal thresholds, and heat pain thresholds.
Electroencephalography (EEG) and evoked potential studies can be used to assess CNS function. The EEG is commonly slowed diffusely—but occasionally more focally—in patients with acute toxic or metabolic encephalopathies, but may be normal in chronic encephalopathies. It is therefore of little use in screening patients for neurotoxic injury. Changes are nonspecific and do not distinguish between toxic and other encephalopathies or between different toxic disorders. Evoked potentials provide some measure of the functional integrity of certain afferent CNS pathways, but normal responses may show marked amplitude variation between subjects and on the two sides of the same subject. Because most neurotoxins produce axonal degeneration, which causes changes in amplitude rather than latency of responses, evoked potentials are of limited utility in evaluating patients with suspected neurotoxicity.
Electromyography (EMG) and nerve conduction studies evaluate the function of the PNS, neuromuscular junctions, and muscle. The findings help to identify subclinical disease, follow disease progression, and characterize the pathophysiologic basis of symptoms. Nerve conduction studies are useful in studying both axonal and demyelinating neuropathies. Needle EMG can indicate the cause of weakness and localize pathologic processes to different regions of the motor units (spinal cord, nerve root, plexus, peripheral nerve, neuromuscular junction, or muscle). When evaluating exposed workers, comparison with appropriate control subjects is important. For example, sedentary office workers should not be used as controls for manual workers, who frequently develop minor abnormalities of nerve conduction as a result of occupationally related, repeated minor trauma or subclinical entrapment neuropathies.
Neuroimaging of the CNS, when normal, does not exclude a neurotoxic disorder. In some instances, however, the findings may show characteristic abnormalities, such as in manganese poisoning, discussed later.
Advances in neuropsychologic test procedures have improved their utility as a screening device. Such test procedures may reveal subtle cognitive dysfunction but the findings are not diagnostic of toxic encephalopathy. Moreover, testing is time-consuming even when self-administered questionnaires and computerized test procedures are used, and thus costly and impractical for screening large numbers of subjects. Careful matching for age, gender, ethnicity, and social, cultural, and educational background is necessary when making comparisons between groups.
Workers with possible occupationally related neurotoxic disorders commonly come to medical attention when exposure has already ceased and laboratory testing is of limited utility. With the exception of screening for heavy metal excretion in the urine or their presence in other tissues, laboratory studies are generally unhelpful in screening for neurotoxic disorders.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here